Endo is a specialty pharmaceutical company committed to helping everyone it serves live their best life through the delivery of quality, life-enhancing therapies. Its decades of proven success come from a global team of passionate employees collaborating to bring the best treatments forward. Together, it boldly transforms insights into treatments benefiting those who need them, when they need them. Show more
Location: | Industry: Pharmaceutical Preparation Manufacturing | Sector: Manufacturing
Market Cap
0.00
52 Wk Range
$N/A - $N/A
Previous Close
$N/A
Open
$N/A
Volume
N/A
Day Range
$N/A - $N/A
Enterprise Value
0.00
Cash
0.00
Avg Qtr Burn
N/A
Insider Ownership
0.00%
Institutional Own.
0.00%
Qtr Updated
06/30/24
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
XIAFLEX (injectable CCH (collagenase clostridium histolyticum)) Details Dupuytren's contracture, Peyronie's disease, Adhesive capsulitis | Approved Quarterly sales | |
Approved Quarterly sales | ||
Collagen clostridium histolyticum (CCH) Details Plantar Fibromatosis | Phase 3 Initiation | |
Collagen clostridium histolyticum (CCH) Details Plantar fasciitis (PFA) | Phase 2 Initiation |